Amanote Research

Amanote Research

    RegisterSign In

Editorial: Vancomycin - A Promising Option for the Treatment of Primary Sclerosing Cholangitis?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14586
Full Text
Open PDF
Abstract

Available in full text

Categories
HepatologyPharmacologyGastroenterology
Date

April 11, 2018

Authors
R. W. Chapman
Publisher

Wiley


Related search

Review Article: The Evidence That Vancomycin Is a Therapeutic Option for Primary Sclerosing Cholangitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Primary Sclerosing Cholangitis

2017English

Primary Sclerosing Cholangitis

2012English

Primary Sclerosing Cholangitis

2020English

Primary Sclerosing Cholangitis

2013English

Editorial: Deciding When to Intervene in Primary Sclerosing Cholangitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Choledocholithiasis Simulating Primary Sclerosing Cholangitis

Grekov's Bulletin of Surgery
2017English

The Best Approach for Diagnosing Primary Sclerosing Cholangitis

Clinics
Medicine
2011English

Editorial: Biologic Therapies for Primary Sclerosing Cholangitis-More Disappointment Than Promise? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy